Role of STAT3 in pancreatic cancer
Exploration of Targeted Anti-tumor Therapy · 17.01.2024 · 5 (1) · 20-33
DOI: 10.37349/etat.2024.00202 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Exploration of Targeted Anti-tumor Therapy, online erschienen am 17.01.2024. Verfasst von Zachary Hamel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pancreatic cancer remains a serious and deadly disease, impacting people globally. There remain prominent gaps in the current understanding of the disease, specifically regarding the role of the signal transducer and activator of transcription (STAT) family of proteins in pancreatic tumors. STAT proteins, particularly STAT3, play important roles in pancreatic cancer, especially pancreatic ductal adenocarcinoma (PDAC), which is the most prevalent histotype. The role of STAT3 across a continuum of molecular processes, such as PDAC tumorigenesis and progression, immune escape, drug resistance and stemness, and modulation of the tumor microenvironment (TME), are only a tip of the iceberg. In some ways, the role of STAT3 in PDAC may hold greater importance than that of oncogenic Kirsten rat sarcoma virus (KRAS). This makes STAT3 a highly attractive target for developing targeted therapies for the treatment of pancreatic cancer. In this review, the current knowledge of STAT3 in pancreatic cancer has been summarized, particularly relating to STAT3 activation in cancer cells, cells of the TME, and the state of targeting STAT3 in pre-clinical and clinical trials of PDAC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Zitieren
APA
Hamel, Z., Sanchez, S., Standing, D., & Anant, S. (2024). Role of STAT3 in pancreatic cancer. Exploration of Targeted Anti-tumor Therapy, 5(1), 20-33. https://doi.org/10.37349/etat.2024.00202
Vancouver
Hamel Z, Sanchez S, Standing D, Anant S. Role of STAT3 in pancreatic cancer. Exploration of Targeted Anti-tumor Therapy. 2024;5(1):20-33. doi:10.37349/etat.2024.00202
BibTeX
@article{Hamel2024,
author = {Hamel, Zachary and Sanchez, Sierra and Standing, David and Anant, Shrikant},
title = {Role of STAT3 in pancreatic cancer},
journal = {Exploration of Targeted Anti-tumor Therapy},
year = {2024},
volume = {5},
number = {1},
pages = {20--33},
doi = {10.37349/etat.2024.00202}
}
EUVIMED